- By Aditya Pratap Singh
- Thu, 30 Apr 2026 03:15 PM (IST)
- Source:JND
Healthcare Stock Buy Rating: The shares of Park Medi World remained in focus during the intraday trade on Thursday as they traded in green early trade despite a massive, broad-based sell-off in the domestic equity market. The shares of the north India-based hospital chain started the session in red at Rs 233.75 as compared to last day's closing of Rs 235.20 on the BSE, mirroring the decline in the broader market.
However, the stock, which is trading near its 52-week high value, recovered from early losses to hit an intraday high of Rs 237, up Rs 1.8, or 0.76 per cent as compared to the last day's closing.
Park Medi World Target Price
Choice Broking Initiates Rating after brokerage firm Choice Institutional Equities initiated 'BUY' coverage. The firm gave a Buy call for the stock and projected a 36 per cent upside potential with a target of Rs 320 per share.
Stock Trades Near 52 Week High
With this, the healthcare stock is trading nearly 4 per cent lower than its 52-week high of Rs 242.45, which it touched on April 28, 2026. Meanwhile, its 52-week low value stood at Rs 138.15.
Stock Market Today
The domestic equity market faced massive decline during the session as the key benchmark indices--Sensex and Nifty-- nosedived over 1.5 per cent during the day on a sharp increase in crude prices due to heightened tension in the Middle East. The decline was also driven by weak global trends and persistent selling by foreign institutional investors (FIIs).
At the time of writing, the BSE Sensex was trading at Rs 77,031.06, down 465.30 points or 0.60 per cent. Nifty50 was quoted at 24,029.15, down 148.50 points or 0.61 per cent.
What Did Brokerage Say?
The brokerage said the company currently has about 3,960 beds and plans to increase this to 5,460 by FY2028 and to 10,000 in the future.
Notably, the expansion is being funded entirely from the company's own revenue. The cost per bed is just Rs. 3.4 million. This is much lower than other new hospital projects (Rs. 80-100 million per bed).
Disclaimer: This story is for informational purposes only. It should not be considered as investment advice.